- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/00 - Drugs for disorders of the cardiovascular system
Patent holdings for IPC class A61P 9/00
Total number of patents in this class: 10294
10-year publication summary
|
391
|
410
|
350
|
524
|
657
|
611
|
672
|
639
|
676
|
170
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
296 |
| Bayer Pharma AG | 1096 |
140 |
| Novartis AG | 11238 |
128 |
| Boehringer Ingelheim International GmbH | 4629 |
88 |
| Bristol-myers Squibb Company | 5080 |
86 |
| F. Hoffmann-La Roche AG | 7958 |
80 |
| Daiichi Sankyo Company, Limited | 1829 |
77 |
| Takeda Pharmaceutical Company Limited | 2961 |
76 |
| The Regents of the University of California | 18943 |
69 |
| AstraZeneca AB | 3042 |
65 |
| Osaka University | 3143 |
65 |
| Sanofi | 3836 |
62 |
| Janssen Pharmaceutica N.V. | 3839 |
52 |
| Bayer AG | 3045 |
51 |
| Amgen Inc. | 3779 |
46 |
| The Johns Hopkins University | 5377 |
46 |
| Merck Patent GmbH | 5909 |
44 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
43 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
40 |
| Ono Pharmaceutical Co., Ltd. | 454 |
38 |
| Other owners | 8702 |